Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00554788 · OUTCOME

Response Rate to the Induction Phase of the Regimen

Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma · Source last updated 2025-01-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
12 weeks after participant received the first dose

What was measured

This study used a modified version of the international criteria for neuroblastoma response. The response rate to the induction phase of the regimen and a corresponding 95% confidence interval will be calculated for all strata combined.

Analysis population: Ineligible patients were excluded from analysis

Groups in this outcome

All Eligible Patients

All eligible Stage 2/3, Stage 4a, and Stage 4b patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Eligible Patients57

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
All Eligible Patients68Not reported5679Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        56
        upper Limit
        79
        value
        68
denoms
  1. counts
    1. group Id
      OG000
      value
      57
    units
    Participants
description
This study used a modified version of the international criteria for neuroblastoma response. The response rate to the induction phase of the regimen and a corresponding 95% confidence interval will be calculated for all strata combined.
dispersion Type
95% Confidence Interval
groups
  1. description
    All eligible Stage 2/3, Stage 4a, and Stage 4b patients
    id
    OG000
    title
    All Eligible Patients
param Type
NUMBER
population Description
Ineligible patients were excluded from analysis
reporting Status
POSTED
time Frame
12 weeks after participant received the first dose
title
Response Rate to the Induction Phase of the Regimen
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice